Artrya, an Australian cardiac software solution provider, in coordination with Alabama-based Huntville Heart Center, will test their AI-based technology devised for heart patients. The companies will conduct an evaluative study based on the previously collected cardiac computed tomography (CT) scans. Once the data is entered, it will be interpreted by the AI technology. The interpretation will be analysed and read by the experts to assess the accuracy of the results. The principal investigator of this experiment informs that this software will identify coronary artery disease more efficiently as compared to human analysts. The world will soon see more partnerships related to AI’s advancements for the treatment of chronic diseases because of the pace at which inventions are being carried out.
Read More from Health IT Analytics